Cogent Biosciences Inc (COGT) — Capital Reinvestment Ratio
Cogent Biosciences Inc (COGT) has a Capital Reinvestment Ratio of 0.11x as of December 2015, meaning it reinvests 0% of its operating cash flow ($17.72 Million) in capital expenditures ($1.99 Million). See COGT net asset quality index to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Cogent Biosciences Inc Capital Reinvestment Ratio (2015–2015)
This chart tracks Cogent Biosciences Inc's Capital Reinvestment Ratio across 1 annual periods. Check COGT total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Cogent Biosciences Inc (2015–2015)
Year-by-year Capital Reinvestment Ratio for Cogent Biosciences Inc from 2015 to 2015. For live market cap and broader valuation context, see COGT company net worth.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2015 | 0.11x | $17.72 Million | $1.99 Million | — |